Position in PFE
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$20,001,917
+$2,356,283 QoQ
Shares Held
712,319
+0.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. PFE ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
This page
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,001,917 | 712,319 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $17,645,634 | 708,660 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $15,937,689 | 625,498 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $13,590,713 | 560,673 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,729,480 | 462,884 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,998,144 | 414,555 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,757,215 | 579,033 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,103,341 | 468,311 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $9,663,354 | 348,229 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,390,397 | 360,903 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,404,901 | 434,275 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,557,521 | 396,879 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,856,609 | 437,662 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,146,133 | 412,688 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,840,117 | 384,829 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,269,275 | 424,743 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $18,619,753 | 359,663 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,311,322 | 360,903 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $7,609,629 | 176,927 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $6,821,554 | 174,197 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $5,761,910 | 159,037 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $5,788,666 | 157,258 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $5,858,525 | 159,633 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $4,433,797 | 135,590 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,173,377 | 127,861 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||